MAPK3 and melanoma: While activation of ERK1/2 by BRAFV600E in melanoma cells inhibits Wnt/β-catenin signaling [27], forced expression of BRAFV600Eenhances Wnt/β-catenin signaling in normal melanocytes (Figure 6B).